Then, colorectal cancer patients were divided into three groups based on the VEGF-C and Reg IV expression; G0 group (both negative group, n=69), G1 group (either positive group, n=104), G2 group (both positive group, n=37). This evidence concerns the gene VEGFC and colorectal cancer.